European Access Academy
A multi-stakeholder initiative aiming to facilitate and support the development of a joint European value framework for the assessment of innovative health technologies
The European Access Academy (EAA) aims to identify key challenges and provide sound input for the implementation of the EU HTA Regulation to help achieve the EC’s mission of improving patient access to life saving innovative technologies.
The
EAA Faculty is acting as Steering Committee for the EAA's work, providing guidance on strategy, supporting peer-reviewed publications and ensuring scientific integrity. As such, it is listed in the EU Transparency Registry and was accepted as a member of the European Commission's HTA Stakeholder Network.
THANK YOU for joining the
EAA Spring Convention 2025
'Approaching Performance Measurement for EU HTA'
Once more we had excellent, heated and very fruitful and constructive discusssions with our experts (including Maya Matthews, Niklas Hedberg, Rui Santos Ivo, Bruno Falissard, Ansgar Hebborn, Andrew Wilson, Josephine Mosset, Bernhard Wörmann, Michael Berntgen, Giovanna Scroccaro, Christian Dierks), the German Oganising Committee (Jürgen Wasem, Frank-Ulrich Fricke, Bernhard Wörmann) and all our virtual and on-site participants.
Thanks so much to all who contributed!
We look forward to continuing the dialogue in November including a first experience exchange on JSC & JCA:
Save the Date of our Fall Convention 2025 in Paris:
November 6/7.
Resources:
Video Recordings, presentations and abstracts are now available here.
Download the EAA Convention Proceedings
Issue #7
(click image to download the pdf)
THANK YOU for joining the EAA Spring Convention's
Adjunct Roundtable: EU HTA for Medical Devices
Approaching Performance Measurement
HTA for Medical Devices needs to consider many different factors and variables many of which differ substantially from those for Medicinal Products. EU HTA poses opportunities but also a range of challenges for the MD that are in scope for JCA. Thanks so much to our expert panel including Frédérique Debroucker, Maya Matthews, Monica Otto, Valentina Strammiello, Adrian Griffin, Andrea Mantovani, Andreas Stange, Frank-Ulrich Fricke, Jürgen Wasem, Marco Marchetti, Rob Nelissen, Ruben Casado, Walter Van Dyck and Yves Verboven who provided input, updates, lots of food for though, and fuelled our discussions on the approach to success measurement in this field.
Presentations & Video Recordings are available NOW.
EAA News & Media Posts
Masters' Project on EU HTA:
The European Access Academy as multi-stakeholder initiative with strong academic focus and footprint cooperates closely with universities, e.g., when they host EAA Conventions, but also beyond, in collaborative projects. As such, we would like to support a Masters’ project at Erasmus University Rotterdam, which is looking at initial experiences with the implementation of the EU HTAR, with a focus on differences between Eastern and Western European Countries.
We believe this is very timely and important research and would appreciate your contribution by participating in this short survey.
Contact in case of questions or concerns:
Evelina Jahimovica (Masters’ student supervised by Prof. Dr. Maureen Rutten-van Mölken)
November 25, 2024: Open Letter from the EAA Faculty to the HTACG and DG Santé on the EU HTA Methods Guidance Documents
November 19, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC for Medical Devices
October 22, 2024: EAA Faculty Feedback on the Draft Implementing Act on JSC
June 25, 2024: EAA Faculty Feedback on the Draft Implementing Act on CoI
June 19, 2024: EAA Presentation at HTAi in Sevilla, Spain
April 14, 2024: EAA Faculty Statement on HTA CG Methodological Guideline for Treatment Comparisons
April 2, 2024: EAA Faculty Feedback on the Draft Implementing Act on JCA
Feb 19, 2024: EAA Post: 'Uncertainty - Friend or Foe'
Feb 06, 2024: EAA Post regarding 'Roadblocks' for EU HTA
Jan 15, 2024: EAA Post regarding the EU HTA Implementing Acts
The EAA is an initiative hosted by Copenhagen University, Utrecht University, Vlerick Business School, Agència de Qualitat I Avaluació Sanitàries de Catalunya, Erasmus University, LUISS Business School and endorsed & funded by:
Springer Healthcare, Abbvie, AstraZeneca, Bayer, Novartis, Pfizer, Roche, Sanofi , vfa, leem and efpia.